TP53 and neoplasm: Frequent P53 mutations can eliminate the inhibitory effects on tumor cells and increase the DNA repair functions of malignant tumor cells such that the killing effects of chemotherapeutic drugs on DNA are reduced, leading to chemotherapeutic drug resistance (Alvarado-Ortiz et al., 2021).